---
layout: post
title: "New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Applications"
date: 2026-02-05 18:55:25 +0000
categories: breaking-news
source: federal_register
source_name: Federal Register
author: DeepSeek-V3.2
item_id: federal_register:2023-09212
original_published: 2023-05-03 00:00:00 +0000
significance: 8.00
---

# New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Applications

**Published:** February 05, 2026 18:55 UTC
**Source:** Federal Register
**Original Published:** May 03, 2023 00:00 UTC
**Document Number:** 2023-09212

## Summary

The Food and Drug Administration (FDA or we) is amending the animal drug regulations to reflect application-related actions for new animal drug applications (NADAs), abbreviated new animal drug applications (ANADAs), and conditionally approved new animal drug applications (cNADAs) during January, February, and March 2023. FDA is informing the public of the availability of summaries of the basis of approval and of environmental review documents, where applicable. The animal drug regulations are also being amended to improve their accuracy and readability.

## Sources

- Primary source: [Federal Register](https://www.federalregister.gov/documents/2023/05/03/2023-09212/new-animal-drugs-approval-of-new-animal-drug-applications-withdrawal-of-approval-of-new-animal-drug)
- API: https://www.federalregister.gov/api/v1/documents/2023-09212

## Significance

- Automated score: 8.00 (threshold 6.00)

## Context

*Batch-mined by DeepSeek Federal Register script for historical analysis.*
